DAA2288 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
383.1% Increase Gene Expression Level |
|
DAA2289 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
frontal lobe |
Human |
FCER1G |
105.3% Increase Gene Expression Level |
|
DAA2290 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
frontal lobe |
Human |
FCER1G |
111.4% Increase Gene Expression Level |
|
DAA2291 |
Fc fragment of IgG binding protein increases with age |
Molecular |
frontal lobe |
Human |
FCGBP |
212.4% Increase Gene Expression Level |
|
DAA2292 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
Molecular |
frontal lobe |
Human |
FCGR2A |
104.3% Increase Gene Expression Level |
|
DAA2293 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
frontal lobe |
Human |
FCGR3B |
52.1% Increase Gene Expression Level |
|
DAA2294 |
Fc fragment of IgG, receptor, transporter, alpha increases with age |
Molecular |
frontal lobe |
Human |
FCGRT |
89.3% Increase Gene Expression Level |
|
DAA2307 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
61.1% Decrease Gene Expression Level |
|
DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
58.0% Decrease Gene Expression Level |
|
DAA2309 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
frontal lobe |
Human |
CXCL16 |
44.1% Increase Gene Expression Level |
|
DAA2324 |
major histocompatibility complex, class II, DM alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DMA |
115.5% Increase Gene Expression Level |
|
DAA2325 |
major histocompatibility complex, class II, DP alpha 1 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DPA1 |
97.1% Increase Gene Expression Level |
|
DAA2326 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
146.8% Increase Gene Expression Level |
|
DAA2341 |
major histocompatibility complex, class I, B increases with age |
Molecular |
frontal lobe |
Human |
HLA-B |
36.5% Increase Gene Expression Level |
|
DAA2342 |
major histocompatibility complex, class I, C increases with age |
Molecular |
frontal lobe |
Human |
HLA-C |
40.1% Increase Gene Expression Level |
|
DAA2343 |
major histocompatibility complex, class I, E increases with age |
Molecular |
frontal lobe |
Human |
HLA-E |
61.2% Increase Gene Expression Level |
|
DAA2344 |
major histocompatibility complex, class I, E increases with age |
Molecular |
frontal lobe |
Human |
HLA-E |
76.9% Increase Gene Expression Level |
|
DAA2345 |
major histocompatibility complex, class I, E increases with age |
Molecular |
frontal lobe |
Human |
HLA-E |
65.7% Increase Gene Expression Level |
|
DAA2346 |
major histocompatibility complex, class I, F increases with age |
Molecular |
frontal lobe |
Human |
HLA-F |
28.9% Increase Gene Expression Level |
|
DAA2347 |
HLA-G histocompatibility antigen, class I, G increases with age |
Molecular |
frontal lobe |
Human |
HLA-G |
28.4% Increase Gene Expression Level |
|
DAA2348 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
37.9% Increase Gene Expression Level |
|
DAA2349 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
22.4% Increase Gene Expression Level |
|
DAA2350 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
32.2% Increase Gene Expression Level |
|
DAA2351 |
Pannexin 2 decreases with age |
Molecular |
frontal lobe |
Human |
PANX2 |
8.1% Decrease Gene Expression Level |
|
DAA2368 |
major histocompatibility complex, class II, DP beta 1 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DPB1 |
76.9% Increase Gene Expression Level |
|